$HBAN

HBAN Maintained by Citigroup -- Price Target Lowered to $19.00

Citigroup maintained a 'Buy' rating for Huntington Bancshares (HBAN) but lowered its price target from $21.00 to $19.00. The company's GF Value is $16.61, indicating it is 5.0% undervalued. HBAN has a GF Score of 87/100, showing strong performance but weak financial strength. Insiders sold $481,100 in shares over the past three months.

Original reporting
Published Oct 26, 2026, 6:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 9:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HBAN
Neutral
medium confidence
Mentioned
$HBAN
Relevance
6/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$HBANNeutralLow
01

Why it matters

A target reduction typically signals caution, potentially prompting short‑term sellers while value investors may see a buying opportunity given the price gap.

02

Market read

Provides a modestly actionable insight for traders monitoring regional bank stocks; the news is not market‑moving but may affect HBAN's short‑term price.

03

What to watch

Insider selling of $481k and a low financial strength rating (2/10) could weigh on sentiment despite the Buy rating.

Relevance 6/10Novelty 5/10Timing: today

Background

The article provides a rating update from GuruFocus, summarizing Citigroup's analyst view, GF Score, and insider activity.

Company-level read

Ticker impact

$HBANNeutralMedium confidence
Context

Citigroup lowered its price target for Huntington Bancshares to $19.00, down from $21.00, while maintaining a Buy rating.

Expected impact

potential downside as investors price in the lower target

Evidence & confidence

Analyst target reductions often lead to short-term price pressure, especially when the new target remains above current price, indicating limited upside.

Market effects

May signal broader caution on regional banks amid rising rates and regulatory scrutiny.

Limited to U.S. mid‑cap banking sector; no immediate macro effect.

Low; impact confined to Huntington Bancshares and comparable U.S. banks.

Counterpoint

The stock remains undervalued at $15.78 versus the new $19 target, offering upside for long‑term investors.

Key entities

  • Citigroup

    Maintains Buy rating on HBAN, lowered price target.

  • GuruFocus

    Supplies GF Score and valuation metrics.

Related articles

$HBANMedAI 8/10

Huntington Bancshares 3Q 2026: Revenue $2.79B, EPS $0.33— 10-Q Summary

Huntington Bancshares reported 3Q 2026 revenue of $2.79B, up 30.8% YoY, and net income of $721M, up 14.6% YoY. EPS was $0.33, down 19.5% YoY, due to acquisition-related expenses. Growth was driven by acquisitions, organic growth, and higher net interest income. Management highlighted progress in integrating recent acquisitions and investing in technology.

$SEBMed

Sweden’s SEB pauses buybacks as Barclays plans further capital returns ahead of Basel 3.1

SEB paused buybacks due to capital buffer pressure from model adjustments and loan growth, reporting a 17.1% CET1 ratio. Barclays announced a GBP 500M buyback, expecting Basel 3.1 to reduce its CET1 ratio but maintain distribution headroom. EU agreed lower capital requirements for qualifying securitisations. Huntington Bancshares saw diverging capital ratios due to interest-rate losses. BPI's provisions fell despite worsening problem-loan metrics.

$HBANMedAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlights: Strong Fee Growth

Huntington Bancshares (HBAN) reported strong Q3 2026 results, with fee revenue up over 15% YoY and commercial loan growth driving a 1.1% increase in loan balances. The company expects 2027 EPS growth of over 20% and ROTCE of 17%-18%. However, it faces challenges like a competitive environment and slightly lowered fee revenue guidance for Q4. The bank repurchased $460 million in stock YTD and plans $1.8-$1.9 billion in buybacks for 2026-2027.

$HBANHighAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlig

Huntington Bancshares (HBAN) reported Q3 2026 earnings with net interest income up 0.9% quarter-over-quarter and 37% year-over-year. Net interest margin increased 4 basis points to 3.25%. Non-interest expense remained flat, while value-added fee revenue rose over 15% year-over-year. Loans grew 1.1% period-end, and deposits increased 0.2%. The company expects 2027 EPS growth of over 20% and plans $1.8-$1.9 billion in share repurchases through 2027.

$HBANMed

Huntington (HBAN) Q3 2026 Earnings Call Transcript

Huntington (HBAN) reported strong Q3 2026 earnings, with C&I growth driven by national commercial strategy. The company expects 2027 EPS to grow over 20% from 2025, with ROTCE in the 17-18% range. They have completed $460 million in share repurchases year-to-date and plan to return substantial capital to shareholders. Huntington's operating model combines local and national commercial banking, with $191 billion in loans and $225 billion in deposits.

$HBANMed

What Huntington Bancshares (HBAN) Said on Its Q3 Earnings Call

Huntington Bancshares (HBAN) reported Q3 earnings with net interest income at $2.1B, up 0.9% sequentially. Net interest margin increased to 3.25%, with management expecting it to remain flat in Q4. Fee revenue grew 15% YoY, and noninterest expense was stable. The company repurchased $460M of common stock YTD and expects $1.8B-$1.9B in repurchases over 2023-2024. Net charge-offs were 31 basis points, with stable credit performance.